SCHEMBL6578602

SCHEMBL6578602

Cc1ccc(N2C(=O)CC(C)(C)c3ccc(OS(=O)(=O)C(F)(F)F)cc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.33
ADORA1 P30542 1/20 0.33
DRD2 P14416 1/20 0.32
HTR1D P28221 1/20 0.32
DRD3 P35462 1/20 0.32
HSD11B1 P28845 1/20 0.32
RXRA P19793 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8613287 0.75 MAPT (0.39) KMT2AGAAMAPTALDH1A1LMNA
SCHEMBL6576642 0.72 POLB (0.41) ARSMN1; SMN2KMT2AMEN1GAA
SCHEMBL17657221 0.71 DRD2 (0.36) KDM4EALDH1A1DRD2HTR1DDRD3
SCHEMBL8771675 0.71 DRD2 (0.39) KDM4EALDH1A1DRD2HTR1DDRD3
SCHEMBL8616526 0.69 RARB (0.42) ARMAPTLMNATSHR
SCHEMBL1091438 0.69 PGR (0.45) SMN1; SMN2KDM4EALDH1A1LMNADRD2
SCHEMBL15280722 0.69 HTR1D (0.36) MAPTDRD2HTR1DDRD3HSD11B1
SCHEMBL2750188 0.68 CA2 (0.57) SMN1; SMN2GAALMNATSHRDRD2
Hydrogen Sulfide SCHEMBL6248782 0.66 CA2 (0.55) SMN1; SMN2GAALMNATSHRDRD2
SCHEMBL17657225 0.66 DRD2 (0.33) SMN1; SMN2ALDH1A1DRD2HTR1DDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed
US-5739338-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS, VISION DEFECTS, VIRICIDES, IMMUNOSUPPRESSANTS ALLERGAN (US) 1998-04-14 US disclosed